Health Care: Drugs

Redhill Biopharma Ltd (RDHL: NASDAQ)

$12.6 0.3 | 2.44%
07/26/16 - 10:12 AM ET
Company Profile
Price and Volume
Recent Price 12.30
52 Week High 15.60
52 Week Low 8.10
Avg. Daily Vol. (Mil) 0.02
Beta (3 year) -0.60
Share Related Items
Mkt Cap (Mil) 156.35
Shares Out (Mil) 12.71
Float (Mil) 0.00
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.30
Current Ratio 9.90
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 78.18K
Price/Book 2.85
Price/Cash Flow -7.10
Per Share Data
Earnings -2.00
Sales 0.00
Book Value 4.32
Cash Flow -1.73
Business Summary
Redhill Biopharma Ltd is an Israeli bio-pharmaceutical company. It is engaged in the development & commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for treatment of inflammatory & gastrointestinal diseases.
General Information
21 Ha'arba'a Street
Tel Aviv, 64739
Industry : Drugs
Sector: Health Care
Employees: 12
CEO: Mr. Dror Ben-Asher
Short Interest
Current Month (Mil) 0.07
Previous Month (Mil) 0.06
Short Interest Ratio (Days) 2.60
Management Effectiveness
Return on Equity n.a.
Return on Assets -35.70
Return on Investments -40.00
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with RDHL

  • Portfolio NameUser Type

Latest RDHL Headlines from TheStreet

More Financial News for RDHL

Press Releases for RDHL

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter